-Reuters
Microcap Firm ZyVersa Therapeutics Shows Promise Despite IPO Volatility, Analyst Initiates With Buy
HC Wainwright initiated coverage on ZyVersa Therapeutics Inc (NASDAQ: ZVSA) with a Buy Rating and a
Related Posts
Russia Restrictions On Facebook, Instagram And X Cost Economy Over $4B In 2023
The economic loss from Russia's internet restrictions highlights the country's increasing isolation from the West and the substantial impact of internet disruptions on the global economy.
Short Sellers Run Scared As Meme Stocks Roar: Why High Short Interest Stocks Keep Ripping
A multitude of stocks with high short interest ripped higher on Monday and continue to rally on Tuesday. The initial moves higher appear to be due to retail traders rushing into heavily shorted names, but the continued momentum may have more to do with short covering.
AgriFORCE Reports On Ongoing Investigation Into Potentially Improper And Illegal Trading Activity In The Company’s Common Stock
AgriFORCE Growing Systems Ltd. ("the Company") (NASDAQ:AGRI, AGRIW)))), an intellectual property (IP)-focused agtech company dedicated to advancing sustainable cultivation practices and food and